Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized AntibodyHong Xu, Nai‐Kong V. Cheung, Ming Cheng et al.|Cancer Immunology Research|2014Cited by 97
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodiesBrian H. Santich, Nai‐Kong V. Cheung, Jeong A Park et al.|Science Translational Medicine|2020Cited by 83
Data from Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized AntibodyHong Xu, Nai‐Kong V. Cheung, Ming Cheng et al.|Unknown|2023Cited by 0
Data from Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized AntibodyHong Xu, Nai‐Kong V. Cheung, Yuedan Chen et al.|Unknown|2023Cited by 0
Supplemental Methods, Figures 1 - 4 from Retargeting T Cells to GD2 Pentasaccharide on Human Tumors Using Bispecific Humanized AntibodyHong Xu, Nai‐Kong V. Cheung, Ming Cheng et al.|Unknown|2023Cited by 0